通过疼痛机制对腰部疼痛进行分类:物理治疗实践的综述
Roberto Tedeschi1, Federica Giorgi2, Daniela Platano1,3
1Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, 40136 Bologna, Italy.
Journal of clinical medicine
|January 25, 2025
概括
分类腰部疼痛 (LBP) 机制 - - 无感觉,神经病和中心敏感化 - - 是有效治疗的关键. 本综述综合了改善临床实践中LBP疼痛分类准确性的标准.
科学领域:
- 物理治疗是物理治疗.
- 疼痛管理 疼痛管理
- 临床诊断 临床诊断 临床诊断
背景情况:
- 腰部疼痛 (LBP) 是全球残疾的主要原因之一.
- 截然不同的疼痛机制 (nociceptive,神经病变,中心敏感) 是LBP的基础.
- 准确的分类对于有针对性的LBP治疗至关重要.
研究的目的:
- 为了提供LBP疼痛机制分类的历史概述.
- 探索过去框架对当前物理治疗诊断概念的影响.
- 综合临床标准,以区分LBP疼痛机制.
主要方法:
- 根据乔安娜·布里格斯研究所的方法进行了范围审查.
- 在多个数据库中进行全面的文献搜索 (MEDLINE,Cochrane,Scopus等). ) 的情况.
- 包括关于成人LBP和疼痛机制分类标准的研究.
主要成果:
- 包含了9项研究,详细说明了 nociceptive,神经病变和中央敏感性疼痛的标准.
- 神经病变性疼痛:灼热,无意识,SLR测试呈阳性. 中心敏感性:广泛的疼痛,过敏症.
- 有验证的工具 (painDETECT,DN4,CSI) 存在于神经和中央敏感.
- 中枢敏感性和神经病痛与更高的残疾和心理痛苦相关.
结论:
- 本综述综合了区分LBP疼痛机制的关键临床标准.
- 它提出了一个实际的框架,以提高物理治疗中的疼痛分类准确性.
- 改进的分类支持更有效,个性化的LBP管理.
相关概念视频
01:25Analgesia and Pain Management
463
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
463
01:20Pain
443
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
443
01:29Spasmolytic Agents: Chemical Classification
853
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
853
01:44Nociception
27.7K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.7K
01:28Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K